Fumihiko Nakamura
Papers
1
Total Citations
9
H-Index
1
About
Fumihiko Nakamura is a leading researcher in the field of stereotactic radiosurgery (SRS) and neuro-oncology, with a particular focus on the treatment of brain metastases. His work has significantly advanced the understanding of how fractionation protocols affect clinical outcomes, especially for aggressive tumor types like melanoma. Nakamura’s most-cited study, “Radiosurgery fractionation and post-treatment hemorrhage development for intact melanoma brain metastases” (2022), has garnered 9 citations and is a key contribution to the literature, demonstrating his ability to address critical complications in SRS—namely, post-treatment hemorrhage risk. By analyzing the interplay between dose fractionation and hemorrhagic events, his research provides actionable insights for optimizing treatment plans to improve patient safety and efficacy. Beyond this, Nakamura’s broader contributions include refining radiosurgical techniques and exploring tumor-specific responses, making him a respected voice in his field. His work is essential reading for clinicians and researchers seeking to balance aggressive tumor control with minimized adverse effects, and it underscores his commitment to translating complex clinical data into practical, life-saving strategies.
Research Focus
Key Achievements
Top Papers
- 1